Skip to main content
TipRanks
Go Ultimate75% OFF

Oxford BioMedica (OXBDF) Revenue

64 Followers

Oxford BioMedica Revenue

Oxford BioMedica had a revenue of 79.84M in the quarter ending Jun 30, 2026, with -16.41%. This bring the company's revenue in the last twelve months to 175.36M, Increased 3.92%. In the fiscal year ending Dec 31, 2025, Oxford BioMedica had annual revenue of 168.74M with 31.01% growth.

Revenue (ttm)
175.36M
Revenue Growth
20.29%
P/S Ratio
5.25
Revenue/Employee
$165,920
Employees
1,017
Market Cap
$885.25M

Revenue Chart

Oxford BioMedica Revenue - Annual

050M100M150M200M37.59M66.78M64.06M87.73M142.80M139.99M89.54M128.80M168.74M201720182019202020212022202320242025
Revenue History
Download to Excel
OXBDF revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025168.74M39.94M31.01%
Dec 31, 2024128.80M39.26M43.84%
Dec 31, 202389.54M-50.45M-36.04%
Dec 31, 2022139.99M-2.81M-1.97%
Dec 31, 2021142.80M55.07M62.77%
Dec 31, 202087.73M23.67M36.95%
Dec 31, 201964.06M-2.72M-4.07%
Dec 31, 201866.78M29.19M77.65%
Dec 31, 201737.59M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
OXBDF175.36M
GB:AVCT113.00K
GB:PRTC6.31M
GB:SCLP0.00
GB:HEMO0.00
GB:AREC-95.00K